OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The rediscovery of platinum-based cancer therapy
Sven Rottenberg, Carmen A. Widmer, Paola Perego
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 37-50
Closed Access | Times Cited: 687
Sven Rottenberg, Carmen A. Widmer, Paola Perego
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 37-50
Closed Access | Times Cited: 687
Showing 1-25 of 687 citing articles:
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690
Platinum-based drugs for cancer therapy and anti-tumor strategies
Chunyu Zhang, Chao Xu, Xueyun Gao, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2115-2132
Open Access | Times Cited: 531
Chunyu Zhang, Chao Xu, Xueyun Gao, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2115-2132
Open Access | Times Cited: 531
Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 513
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 513
Targeting replication stress in cancer therapy
Alexandre André Balieiro Anastácio da Costa, Dipanjan Chowdhury, Geoffrey I. Shapiro, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 38-58
Closed Access | Times Cited: 190
Alexandre André Balieiro Anastácio da Costa, Dipanjan Chowdhury, Geoffrey I. Shapiro, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 38-58
Closed Access | Times Cited: 190
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 186
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 186
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
Yuying Tan, Junjie Li, Guangyuan Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 148
Yuying Tan, Junjie Li, Guangyuan Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 148
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Metallodrugs in cancer nanomedicine
Quim Peña, Alec Wang, Orysia Zaremba, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2544-2582
Closed Access | Times Cited: 144
Quim Peña, Alec Wang, Orysia Zaremba, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2544-2582
Closed Access | Times Cited: 144
Copper-based metal–organic frameworks for biomedical applications
Ju‐E Cun, Fan Xi, Qingqing Pan, et al.
Advances in Colloid and Interface Science (2022) Vol. 305, pp. 102686-102686
Closed Access | Times Cited: 144
Ju‐E Cun, Fan Xi, Qingqing Pan, et al.
Advances in Colloid and Interface Science (2022) Vol. 305, pp. 102686-102686
Closed Access | Times Cited: 144
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 119
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 119
Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicineviacuproptosis
Yao Lu, Qingqing Pan, Wenxia Gao, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 33, pp. 6296-6306
Closed Access | Times Cited: 111
Yao Lu, Qingqing Pan, Wenxia Gao, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 33, pp. 6296-6306
Closed Access | Times Cited: 111
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 110
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 110
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Dengshuai Wei, Yong Sun, Hu Zhu, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23223-23261
Closed Access | Times Cited: 109
Dengshuai Wei, Yong Sun, Hu Zhu, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23223-23261
Closed Access | Times Cited: 109
The gold complex auranofin: new perspectives for cancer therapy
Farah H. Abdalbari, Carlos M. Telleria
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Farah H. Abdalbari, Carlos M. Telleria
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
Guillermo Moreno‐Alcántar, Pierre Picchetti, Angela Casini
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 105
Guillermo Moreno‐Alcántar, Pierre Picchetti, Angela Casini
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 105
Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy
Lei Cao, Huixiang Tian, Man Fang, et al.
Biomaterials (2022) Vol. 290, pp. 121856-121856
Open Access | Times Cited: 94
Lei Cao, Huixiang Tian, Man Fang, et al.
Biomaterials (2022) Vol. 290, pp. 121856-121856
Open Access | Times Cited: 94
The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Simultaneous Photoactivation of cGAS‐STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer Immunotherapy
Yu‐Yi Ling, Xiaoyu Xia, Hao Liang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 43
Closed Access | Times Cited: 80
Yu‐Yi Ling, Xiaoyu Xia, Hao Liang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 43
Closed Access | Times Cited: 80
Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics
Xidan Wen, Rui Zhang, Yuxuan Hu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Xidan Wen, Rui Zhang, Yuxuan Hu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Cuproptosis: Harnessing Transition Metal for Cancer Therapy
Wuyin Wang, Wentao Mo, Zishan Hang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19581-19599
Closed Access | Times Cited: 80
Wuyin Wang, Wentao Mo, Zishan Hang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19581-19599
Closed Access | Times Cited: 80
Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis
Yongkang Yu, Qinzhen Cheng, Xiaoyuan Ji, et al.
Science Advances (2022) Vol. 8, Iss. 49
Open Access | Times Cited: 77
Yongkang Yu, Qinzhen Cheng, Xiaoyuan Ji, et al.
Science Advances (2022) Vol. 8, Iss. 49
Open Access | Times Cited: 77
Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 75
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 75
Targeted nanomedicine in cisplatin-based cancer therapeutics
Yu Han, Panyue Wen, Junjie Li, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 709-720
Open Access | Times Cited: 73
Yu Han, Panyue Wen, Junjie Li, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 709-720
Open Access | Times Cited: 73
Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes
Lu Yang, Shuming Dong, Shili Gai, et al.
Nano-Micro Letters (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 65
Lu Yang, Shuming Dong, Shili Gai, et al.
Nano-Micro Letters (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 65
